REG - Belluscura PLC - Response to Share Price Movement

BelluscuraAnnouncement

13/05/2025 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250513:nRSM4899Ia&default-theme=true

RNS Number : 4899I  Belluscura PLC  13 May 2025

13 May 2025

 

 

Belluscura plc

("Belluscura" or the "Company")

 

             Response to Share Price Movement

 

Belluscura plc (AIM: BELL), a UK medical device company focused on developing
oxygen enrichment technology spanning broad industries and therapies, notes
the recent movements in its share price.

 

On Friday 9 May 2025 the Company issued a notification which included, inter
alia, a comprehensive trading update and commencement of strategic review.
There have been no notifiable developments since the publication of that
announcement. As stated in that notification, the Company will provide further
updates as and when appropriate.

 

Enquiries:

For further information please contact:

 

 Belluscura plc                                               Tel: +44 (0)20 3128 8100
 Paul Tuson, Chairman

 Robert Rauker, Chief Executive Officer

                                                              Tel: +44 (0)20 3368 3550

 SPARK Advisory Partners Limited

 Nominated Adviser
 Neil Baldwin / Jade Bayat

                                                              Tel: +44 (0)20 3903 7715

 Dowgate Capital Limited

 Joint Broker
 James Serjeant / Colin Climie (Sales and Corporate Broking)

 Russell Cook / Daniel Ingram (Corporate Finance)

 Allenby Capital Ltd                                          Tel: +44 (0)20 3328 5656

 Joint Broker
 Guy McDougall / Amrit Nahal (Sales and Corporate Broking)

 Jeremy Porter / Lauren Wright (Corporate Finance)

 MHP                                                          Tel: +44 (0)20 3128 8100

 Financial PR & Investor Relations                            email: Belluscura@mhpgroup.com (about:blank)
 Katie Hunt/Matthew Taylor

 

For further information, please visit https://ir.belluscura.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SPCBBGDUDUBDGUX